- Home
- TRUP vs NVCR Comparison
TRUP vs NVCR Comparison
Compare TRUP & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUP
- NVCR
- Stock Information
- Founded
- TRUP 2000
- NVCR 2000
- Country
- TRUP United States
- NVCR Switzerland
- Employees
- TRUP N/A
- NVCR N/A
- Industry
- TRUP Medical Specialities
- NVCR Medical/Dental Instruments
- Sector
- TRUP Health Care
- NVCR Health Care
- Exchange
- TRUP Nasdaq
- NVCR Nasdaq
- Market Cap
- TRUP 1.4B
- NVCR 2.3B
- IPO Year
- TRUP 2014
- NVCR 2015
- Fundamental
- Price
- TRUP $33.58
- NVCR $20.06
- Analyst Decision
- TRUP Buy
- NVCR Buy
- Analyst Count
- TRUP 6
- NVCR 5
- Target Price
- TRUP $46.60
- NVCR $33.40
- AVG Volume (30 Days)
- TRUP 943.1K
- NVCR 1.1M
- Earning Date
- TRUP 05-01-2025
- NVCR 05-01-2025
- Dividend Yield
- TRUP N/A
- NVCR N/A
- EPS Growth
- TRUP N/A
- NVCR N/A
- EPS
- TRUP N/A
- NVCR N/A
- Revenue
- TRUP $1,285,684,000.00
- NVCR $605,220,000.00
- Revenue This Year
- TRUP N/A
- NVCR $3.41
- Revenue Next Year
- TRUP $5.05
- NVCR $9.24
- P/E Ratio
- TRUP N/A
- NVCR N/A
- Revenue Growth
- TRUP 15.97
- NVCR 18.82
- 52 Week Low
- TRUP $19.69
- NVCR $11.70
- 52 Week High
- TRUP $57.90
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- TRUP 35.59
- NVCR 42.06
- Support Level
- TRUP $31.76
- NVCR $17.10
- Resistance Level
- TRUP $34.65
- NVCR $21.55
- Average True Range (ATR)
- TRUP 1.89
- NVCR 1.27
- MACD
- TRUP 0.25
- NVCR 0.28
- Stochastic Oscillator
- TRUP 61.67
- NVCR 56.96
About TRUP Trupanion Inc.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.